CPC C07D 211/34 (2013.01) [A61K 9/0053 (2013.01); A61K 9/2009 (2013.01); A61K 9/2013 (2013.01); A61K 9/2018 (2013.01); A61K 9/2054 (2013.01); A61K 9/4825 (2013.01); A61K 9/4858 (2013.01); A61K 9/4866 (2013.01); A61K 31/445 (2013.01); A61K 47/38 (2013.01); A61P 25/14 (2018.01); C07D 211/26 (2013.01); C07B 2200/13 (2013.01)] | 35 Claims |
1. A method of treating an essential tremor in a patient in need thereof, comprising administering to the patient a sufficient amount of an oral dosage form comprising a crystalline anhydrous Form C hydrochloride of Formula (II)
and a modified-release polymer,
wherein the crystalline anhydrous Form C hydrochloride of Formula (II) is characterized by an X-ray powder diffraction (XRPD) pattern comprising one or more of the following peaks at the diffraction angle 2θ: 26.6±0.2, 16.2±0.2, 17.4±0.2, 22.6±0.2, and 11.5±0.2.
|